Iacobucci, Ilaria
Wen, Ji
Meggendorfer, Manja
Choi, John K.
Shi, Lei
Pounds, Stanley B. http://orcid.org/0000-0002-9167-2114
Carmichael, Catherine L.
Masih, Katherine E. http://orcid.org/0000-0002-0809-668X
Morris, Sarah M.
Lindsley, R. Coleman
Janke, Laura J.
Alexander, Thomas B. http://orcid.org/0000-0002-0484-1574
Song, Guangchun
Qu, Chunxu
Li, Yongjin
Payne-Turner, Debbie
Tomizawa, Daisuke http://orcid.org/0000-0003-1520-7007
Kiyokawa, Nobutaka
Valentine, Marcus
Valentine, Virginia
Basso, Giuseppe
Locatelli, Franco
Enemark, Eric J.
Kham, Shirley K. Y.
Yeoh, Allen E. J. http://orcid.org/0000-0002-6454-976X
Ma, Xiaotu
Zhou, Xin
Sioson, Edgar
Rusch, Michael http://orcid.org/0000-0002-5363-1848
Ries, Rhonda E.
Stieglitz, Elliot http://orcid.org/0000-0001-7032-4623
Hunger, Stephen P.
Wei, Andrew H.
To, L Bik
Lewis, Ian D.
D’Andrea, Richard J.
Kile, Benjamin T.
Brown, Anna L.
Scott, Hamish S. http://orcid.org/0000-0002-5813-631X
Hahn, Christopher N.
Marlton, Paula
Pei, Deqing
Cheng, Cheng
Loh, Mignon L.
Ebert, Benjamin L.
Meshinchi, Soheil
Haferlach, Torsten
Mullighan, Charles G. http://orcid.org/0000-0002-1871-1850
Article History
Received: 19 July 2018
Accepted: 13 February 2019
First Online: 29 March 2019
Competing interests
: M.M., employed by MLL Munich Leukemia Laboratory; R.C.L., research funding from MedImmune and Jazz, and consulting fees from Takeda; B.L.E., research funding from Celgene and Deerfield, and consulting fees from GRAIL; T.H., equity ownership of MLL Munich Leukemia Laboratory; C.G.M., research funding from Loxo Oncology for TRK inhibitors in acute lymphoblastic leukemia, and Abbvie and Pfizer for studies unrelated to those described herein. C.G.M. has received honoraria and travel support from Pfizer and Amgen.